Thumbnail Image
Item

Etoposide as Salvage Therapy for Cytokine Storm due to COVID-19

Patel, Maulin
; ; ; 
Desai, Parag
; 
Chandar, Ashwin
; 
Bromberg, Michael
; ; 
Criner, Gerard J.
Citations
Altmetric:
Genre
Pre-print
Date
2020-09-12
Advisor
Committee member
Group
COVID-19 Research Group (Temple University)
Department
Thoracic Medicine and Surgery
Hematology and Oncology
Rheumatology
Subject
COVID-19
 Etoposide
Permanent link to this record
http://hdl.handle.net/20.500.12613/4153
Collections
COVID-19 Research
Show all metadata
Files
Thumbnail Image
Patel-PrePrint-2020.pdf
Adobe PDF, 161.8 KB
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1016/j.chest.2020.09.077
Abstract
Coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality because of a lack of effective therapies. Therapeutic strategies under investigation target the overactive cytokine response with anti-cytokine or immunomodulators therapies. We present a unique case of severe cytokine storm resistant to multiple anti-cytokine therapies, but eventually responsive to etoposide. Thus, etoposide may have a role as salvage therapy in treatment of cytokine storm in COVID-19. To our knowledge, this is the first reported case of use of etoposide in COVID-19.
Description
Citation
Citation to related work
Elsevier
Has part
Chest
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
Embedded videos